[Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73]. 1982

G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi

Seventy-five young recruits received an intramuscular dose of anti-influenza virus vaccine containing 300 U.I. of A/Texas/1/77 (H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73 strains. Antibody responses were detected by HI and SRH tests: immunogenicity of the preparation was different for the individual vaccine strain in spite of the similar amount of antigenic content, and the immunity conferred by vaccine strains did not significantly extend to new influenza virus strains which prevailed in 1979/80 winter season with the exception for A/Brazil/11/78 (H1N1).

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008297 Male Males
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated

Related Publications

G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
December 1981, The American review of respiratory disease,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
January 1980, Canadian journal of public health = Revue canadienne de sante publique,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
January 1983, Reviews of infectious diseases,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
January 1981, Mikrobiologicheskii zhurnal,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
January 1980, Archives of virology,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
April 1985, The Journal of infectious diseases,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
January 1972, Minerva medica,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
August 1985, Nihon juigaku zasshi. The Japanese journal of veterinary science,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
January 1980, Comparative immunology, microbiology and infectious diseases,
G Mancini, and M Andreoni, and G Arangio-Ruiz, and C Sarrecchia, and I Donatelli, and S Resta, and C Rozera, and P Sordillo, and G Rocchi
January 1969, Bulletin of the World Health Organization,
Copied contents to your clipboard!